SCHEMBL30253292

SCHEMBL30253292

CCOC(=O)COc1ccc(Br)nc1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.48
MAPT P10636 11/20 0.48
NPSR1 Q6W5P4 4/20 0.48
HTT P42858 2/20 0.48
LMNA P02545 6/20 0.47
HPGD P15428 5/20 0.47
MAPK1 P28482 3/20 0.47
TLR9 Q9NR96 2/20 0.47
MITF O75030 1/20 0.47
HSP90AA1 P07900 1/20 0.47
PKM P14618 1/20 0.47
RAB9A P51151 7/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
NPC1 O15118 5/20 0.47
S1PR4 O95977 3/20 0.47
ITGA4 P13612 1/20 0.47
S1PR1 P21453 1/20 0.47
NOD2 Q9HC29 1/20 0.47
MEN1 O00255 3/20 0.46
POLB P06746 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3072548 1.00 ALDH1A1 (0.48) ALDH1A1MAPTNPSR1HTTLMNA
SCHEMBL16900169 0.87 ALDH1A1 (0.62) ALDH1A1MAPTNPSR1HTTLMNA
SCHEMBL15529186 0.87 ALDH1A1 (0.47) ALDH1A1MAPTNPSR1HTTLMNA
SCHEMBL3829296 0.85 ALDH1A1 (0.45) ALDH1A1MAPTNPSR1HTTLMNA
SCHEMBL2921634 0.82 ALDH1A1 (0.47) ALDH1A1MAPTNPSR1HTTLMNA
SCHEMBL2921638 0.82 ALDH1A1 (0.47) ALDH1A1MAPTNPSR1HTTLMNA
SCHEMBL1812380 0.79 ALDH1A1 (0.41) ALDH1A1MAPTNPSR1HTTLMNA
SCHEMBL1809935 0.78 FBP1 (0.50) ALDH1A1MAPTLMNAHPGDRAB9A
SCHEMBL3829294 0.77 MAPT (0.44) ALDH1A1MAPTNPSR1HTTLMNA
SCHEMBL3829304 0.77 MAPT (0.44) ALDH1A1MAPTNPSR1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405353-A1 NEW COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION F. Hoffmann-La Roche AG (CH) 2024-07-31 EP disclosed
WO-2023041757-A1 NEW COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2023-03-23 WO disclosed
EP-4126855-A1 COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION F. Hoffmann-La Roche AG (CH) 2023-02-08 EP disclosed